193 related articles for article (PubMed ID: 12217248)
41. Inclusion body myositis in Alzheimer's disease.
Roos PM; Vesterberg O; Nordberg M
Acta Neurol Scand; 2011 Sep; 124(3):215-7. PubMed ID: 21824117
[TBL] [Abstract][Full Text] [Related]
42. BACE1 and BACE2 in pathologic and normal human muscle.
Vattemi G; Engel WK; McFerrin J; Pastorino L; Buxbaum JD; Askanas V
Exp Neurol; 2003 Feb; 179(2):150-8. PubMed ID: 12618121
[TBL] [Abstract][Full Text] [Related]
43. Cultured inclusion-body myositis muscle fibers do not accumulate beta-amyloid precursor protein and can be innervated.
McFerrin J; Engel WK; Askanas V
Neurology; 1999 Dec; 53(9):2184-7. PubMed ID: 10599804
[TBL] [Abstract][Full Text] [Related]
44. Increased BACE1 mRNA and noncoding BACE1-antisense transcript in sporadic inclusion-body myositis muscle fibers--possibly caused by endoplasmic reticulum stress.
Nogalska A; Engel WK; Askanas V
Neurosci Lett; 2010 May; 474(3):140-143. PubMed ID: 20236612
[TBL] [Abstract][Full Text] [Related]
45. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
46. [Sporadic inclusion body myositis and amyloid].
Aoki M; Suzuki N
Brain Nerve; 2014 Jul; 66(7):739-48. PubMed ID: 24998819
[TBL] [Abstract][Full Text] [Related]
47. Alzheimer's disease and Creutzfeldt-Jakob disease: overlap of pathogenic mechanisms.
DeArmond SJ
Curr Opin Neurol; 1993 Dec; 6(6):872-81. PubMed ID: 7904883
[TBL] [Abstract][Full Text] [Related]
48. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
Hasegawa T
Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446
[TBL] [Abstract][Full Text] [Related]
49. Myostatin precursor protein is increased and associates with amyloid-beta precursor protein in inclusion-body myositis culture model.
Wojcik S; Nogalska A; McFerrin J; Engel WK; Oledzka G; Askanas V
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):238-42. PubMed ID: 17359364
[No Abstract] [Full Text] [Related]
50. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
[TBL] [Abstract][Full Text] [Related]
51. Fourteen newly recognized proteins at the human neuromuscular junctions--and their nonjunctional accumulation in inclusion-body myositis.
Askanas V; Engel WK; Alvarez RB
Ann N Y Acad Sci; 1998 May; 841():28-56. PubMed ID: 9668220
[No Abstract] [Full Text] [Related]
52. Treatment of inclusion body myositis.
Cherin P
Curr Opin Rheumatol; 1999 Nov; 11(6):456-61. PubMed ID: 10551668
[TBL] [Abstract][Full Text] [Related]
53. Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers.
Paciello O; Wójcik S; Engel WK; McFerrin J; Askanas V
Acta Myol; 2006 Jun; 25(1):13-22. PubMed ID: 17039976
[TBL] [Abstract][Full Text] [Related]
54. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
55. Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.
Kannanayakal TJ; Mendell JR; Kuret J
Neurosci Lett; 2008 Jan; 431(2):141-5. PubMed ID: 18191026
[TBL] [Abstract][Full Text] [Related]
56. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
57. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
[TBL] [Abstract][Full Text] [Related]
58. Sphingolipids: critical players in Alzheimer's disease.
van Echten-Deckert G; Walter J
Prog Lipid Res; 2012 Oct; 51(4):378-93. PubMed ID: 22835784
[TBL] [Abstract][Full Text] [Related]
59. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease.
Martins IJ; Berger T; Sharman MJ; Verdile G; Fuller SJ; Martins RN
J Neurochem; 2009 Dec; 111(6):1275-308. PubMed ID: 20050287
[TBL] [Abstract][Full Text] [Related]
60. Intracellular β-amyloid accumulation leads to age-dependent progression of Ca2+ dysregulation in skeletal muscle.
Lopez JR; Shtifman A
Muscle Nerve; 2010 Nov; 42(5):731-8. PubMed ID: 20665519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
